ESR1 and breast cancer: Conversely, reverse Mendelian randomization analysis reveals that genetically predicted estrogen receptor-positive breast cancer increases the incidence of UC (OR = 1.098; 95% CI: 1.032-1.168; p = 0.003) (Figure 4).